Comparison of Prospective and Retrospective Environmental Risk Assessments of Human Pharmaceuticals

  • T. Knacker
  • M. Liebig
  • J. F. Moltmann


Water Framework Directive Environmental Risk Assessment Assessment Factor Risk Quotient Unacceptable Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brain RA, Johnson DJ, Richards SM, Sanderson H, Sibley PK, Solomon KR (2004) Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day static-renewal test. Environ Toxicol Chem 23:371–382CrossRefGoogle Scholar
  2. Calow P, Forbes VE (2003) Does ecotoxicology inform ecological risk assessment? Environ Sci Technol, 146A–151AGoogle Scholar
  3. CEC (2001) White Paper – Strategy for a future chemicals policy. COM(2001) 88 final, 32 ppGoogle Scholar
  4. EC (European Council) (1991) Council Directive of 15 July 1991 concerning the placing of plant protection products on the market (91/414/EEC). Official Journal of the European Communities No. L 230, 19.8.1991, p 1Google Scholar
  5. EC (European Commission) (2000) European Water Framework Directive (WFD), Directive 2000/60/ EC of the European Parliament and the Council of 23 October 2000 establishing a framework for the Community action in the field of water policy, BrusselsGoogle Scholar
  6. EC (European Commission) (2003) Technical Guidance Document on Risk Assessment in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, Parts I, II and IV. European Communities, 2003. EUR 20418 EN/1Google Scholar
  7. EMEA (2006) Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00 European Medicines Agency – Pre-Authorisation Evaluation of Medicines for Human Use (Committee for Medicinal Products for Human Use)Google Scholar
  8. Ferrari B, Paxéus N, Lo Guidice R, Pollio A, Garric J (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid and diclofenac. Ecotoxicol Environ Saf 55:359–370CrossRefGoogle Scholar
  9. Knacker T, Moltmann JF, Liebig M (2006) Environmental risk assessment. In: Ternes T, Joss A (eds) Human pharmaceuticals, hormones and fragrances – A challenge for urban water management. IWA Publishing, London, New York, pp 121–148Google Scholar
  10. Kopf G (1997) Wirkung endokriner Stoffe in Biotests mit Wasserorganismen. Stoffe mit endokriner Wirkung im Wasser 50:82–101 (Oldenbourg, München)Google Scholar
  11. Lepper P (2005) Manual on the Methodological Framework to Derive Environmental Quality Standards for Priority Substances in accordance with Article 16 of the WFD (2000/60/EC). Fraunhofer- Institute for Molecular Biology and Applied Ecology, Schmallenberg, Germany, 15 September 2005, 47 ppGoogle Scholar
  12. Liebig M (2005) Untersuchungen zu Umweltrisikoabschätzungen von Humanpharmaka und Inhaltsstoffen von Körperpflegeprodukten vor dem Hintergrund europäischer Bewertungskonzepte. Dissertation, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Germany, 220 ppGoogle Scholar
  13. Liebig M, Moltmann JF, Knacker T (2006) Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products. Environ Sci Poll Res 13:110–119CrossRefGoogle Scholar
  14. Löffler D, Römbke J, Meller M, Ternes T (2005) Environmental fate of pharmaceuticals in water/sediment systems. Environ Sci Technol 39:5209–5218CrossRefGoogle Scholar
  15. Oetken M, Nentwig G, Löffler D, Ternes T, Oehlmann J (2005) Effects of pharmaceuticals on aquatic invertebrates. Part I. The antiepileptic drug carbamazepine. Arch Environ Cont Toxic 49:353-361CrossRefGoogle Scholar
  16. Wenzel A, Schäfers C, Vollmer G, Michna H, Diel P (2001) Research efforts towards the development and validation of a test method for the identification of endocrine disrupting chemicals, Final report, contract B6-7920/98/000015, Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., München, GermanyGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • T. Knacker
    • 1
  • M. Liebig
    • 1
  • J. F. Moltmann
    • 1
  1. 1.ECT Oekotoxikologie GmbHGermany

Personalised recommendations